Three new purine nucleoside analogues, pentostatin, cladribine and fludarabine, have demonstrated remarkable clinical activity in a variety of hematologic malignancies. Although they share structural similarities, their plasma pharmacology, metabolism, and mechanisms of action differ qualitatively and quantitatively. The plasma pharmacokinetics and the cellular pharmacodynamics are reviewed to provide a basis for dose schedules and rationales for combinations with other anticancer drugs.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
purine nucleoside
8
nucleoside analogues
8
pharmacology purine
4
analogues three
4
three purine
4
analogues pentostatin
4
pentostatin cladribine
4
cladribine fludarabine
4
fludarabine demonstrated
4
demonstrated remarkable
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!